Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)

Published on Nov 12, 2013in British Journal of Cancer5.791
· DOI :10.1038/BJC.2013.620
S. Nicholson1
Estimated H-index: 1
(Imperial College Healthcare),
Emma Hall57
Estimated H-index: 57
(ICR: Institute of Cancer Research)
+ 10 AuthorsAmit Bahl24
Estimated H-index: 24
Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)
📖 Papers frequently viewed together
202 Citations
63 Citations
74 Citations
#1Giuseppe Di LorenzoH-Index: 34
#2Carlo BuonerbaH-Index: 27
Last. Sabino De PlacidoH-Index: 62
view all 15 authors...
UNLABELLED: What's known on the subject? and What does the study add? Metastatic or locally advanced squamous cell carcinoma of the penis (SCCP) is generally incurable, but it can be palliated with systemic chemotherapy. Two retrospective studies, involving <10 patients each, showed that cisplatin plus continuous infusion of 5-fluorouracil (5-FU) may be effective and well tolerated. Cisplatin, methotrexate and bleomycin, cisplatin and irinotecan and taxanes can also play an important role for pa...
49 CitationsSource
#1Roberto SalvioniH-Index: 31
#2Nicola NicolaiH-Index: 28
Last. Andrea NecchiH-Index: 13
view all 9 authors...
4639 Background: Treatment of patients (pts) with advanced penile SCC is very often unsuccessful. Single agents or combination therapies (Rx) combined with surgery achieved unsatisfactory results. We evaluated TPF in either neoadjuvant (NA), adjuvant (A) or metastatic (M) setting in a single-center pilot trial. Methods: 3-4 courses of paclitaxel 120 mg/m2 d1 or docetaxel 75 mg/m2 d1 + cisplatin 75 mg/m2 d1 + 5-fluorouracil (5FU) 96 hrs continuous infusion 750 mg/m2 from d1, q3wks were provided. ...
5 CitationsSource
#1Lance C. Pagliaro (University of Texas MD Anderson Cancer Center)H-Index: 48
#2Dallas Williams (University of Texas MD Anderson Cancer Center)H-Index: 11
Last. Curtis A. Pettaway (University of Texas MD Anderson Cancer Center)H-Index: 65
view all 9 authors...
Purpose Men with penile squamous cell carcinoma and regional lymph node involvement have a low probability of survival with lymphadenectomy alone. A multimodal approach to treatment is desirable for such patients. We performed a phase II study of neoadjuvant chemotherapy with the objective of determining the response rate, time to progression (TTP), and overall survival (OS) among patients with bulky adenopathy. Patients and Methods Eligible patients had stage N2 or N3 (stage III or stage IV) pe...
202 CitationsSource
#1Giorgio Pizzocaro (University of Milan)H-Index: 32
#2Nicola NicolaiH-Index: 28
Last. Angelo MilaniH-Index: 16
view all 3 authors...
Abstract Background Chemotherapy is emerging in the management of advanced penile cancer. Objective To evaluate the therapeutic activity of taxanes (T) in combination with cisplatin-fluorouracil (PF) for salvage of primarily unresectable or relapsed nodal metastases from squamous cell carcinoma (SCC) of the penis. Design, setting, and participants Six consecutive patients were treated at Istituto Nazionale Tumori (INT), Milano, with neoadjuvant paclitaxel, cisplatin, and 5-fluorouracil (TPF) for...
95 CitationsSource
#1Christine Theodore (Institut Gustave Roussy)H-Index: 58
Last. R. D. T. OliverH-Index: 1
view all 9 authors...
Background: The aim of this study is to determine efficacy and feasibility of the combination regimen irinotecan and cisplatin in patients with cisplatin advanced penile cancer. Patients and methods: Patients with T3, T4, N1, N2, N3 or M1 cisplatin advanced penile cancer were treated with a combination of irinotecan (60 mg/m 2 ) on days 1, 8 and 15 and cisplatin (80mg/m 2 ) administered every 28 days. Patients were treated either in the neo-adjuvant setting for T3 or N1-N2 disease with a maximum...
74 CitationsSource
#1Marshall R. Posner (Harvard University)H-Index: 76
#2Diane HershockH-Index: 13
Last. Robert I. Haddad (Harvard University)H-Index: 73
view all 29 authors...
Background A randomized phase 3 trial of the treatment of squamous-cell carcinoma of the head and neck compared induction chemotherapy with docetaxel plus cisplatin and fluorouracil (TPF) with cisplatin and fluorouracil (PF), followed by chemoradiotherapy. Methods We randomly assigned 501 patients (all of whom had stage III or IV disease with no distant metastases and tumors considered to be unresectable or were candidates for organ preservation) to receive either TPF or PF induction chemotherap...
1,272 CitationsSource
#1Jan B. Vermorken (University of Antwerp)H-Index: 87
#2E. RemenarH-Index: 2
Last. Jean-Louis LefebvreH-Index: 34
view all 18 authors...
BACKGROUND: Phase 2 studies suggest that the standard regimen of cisplatin and fluorouracil (PF) plus docetaxel (TPF) improves outcomes in squamous-cell carcinoma of the head and neck. We compared TPF with PF as induction chemotherapy in patients with locoregionally advanced, unresectable disease. METHODS: We randomly assigned eligible patients between the ages of 18 and 70 years who had stage III or stage IV disease and no distant metastases to receive either TPF (docetaxel and cisplatin, day 1...
1,231 CitationsSource
#1Carlos E. Bermejo (University of Texas MD Anderson Cancer Center)H-Index: 6
#1Carlos E. Bermejo (University of Texas MD Anderson Cancer Center)H-Index: 6
Last. Curtis A. Pettaway (University of Texas MD Anderson Cancer Center)H-Index: 65
view all 6 authors...
Purpose: Combination chemotherapy for advanced penile cancer can produce partial response rates of up to 64%. Complete responses are rare, suggesting a need for adjunct therapies to facilitate cure. We evaluated patients with metastases who underwent surgical consolidation after responding to chemotherapy.Materials and Methods: We reviewed the records of 59 patients with advanced penile carcinoma treated from 1985 to 2000 and identified 10 treated with surgical consolidation after demonstrating ...
121 CitationsSource
#1Markus Joerger (Kantonsspital St. Gallen)H-Index: 17
#2T Warzinek (Kantonsspital St. Gallen)H-Index: 1
Last. Silke Gillessen (Kantonsspital St. Gallen)H-Index: 58
view all 6 authors...
Penile cancer is rare in Western countries. High-risk patients are considered for prophylactic inguinal lymphadenectomy. For advanced disease, a triplet drug regimen consisting of bleomycin, methotrexate, and cisplatin is the most active combination tested so far. A 62-year-old man with penile cancer underwent partial penile amputation but presented 10 months later with inguinal nodal metastasis. He received three cycles of paclitaxel/carboplatin with marked clinical and radiologic (computed tom...
30 CitationsSource
966 CitationsSource
Cited By64
#1Wing K Liu (St George’s University Hospitals NHS Foundation Trust)
#2Reena Patel (St. George's University)
Last. Mehran Ashfar (St George’s University Hospitals NHS Foundation Trust)
view all 9 authors...
Objective:This study aimed to provide real-world data on the multidisciplinary management of metastatic penile squamous-cell carcinoma (mpSCC) patients and their survival outcomes, particularly tho...
Penile squamous cell carcinoma (PSCC) is a rare malignancy with poor survival after standard treatment. Although genomic alterations of PSCC have been characterized in several latest studies, the association between the formation of somatic landscape and regional lymph node metastasis (LNM), an important predictor for patient survival, has not been comprehensively investigated. Here, we collected formalin-fixed paraffin-embedded tumor tissue and matched normal samples of 32 PSCC patients, includ...
#1Jad ChahoudH-Index: 3
#1Jad ChahoudH-Index: 8
Last. Philippe E. SpiessH-Index: 35
view all 3 authors...
Penile squamous cell carcinoma (PSCC) is a rare cancer, with approximately 2000 new cases in the United States and 35,000 globally every year. Multiple risk factors are involved in PSCC, but most importantly, the high-risk human papillomavirus infection is thought to be present in approximately 50% of cases. Penile squamous cell carcinoma presents as localized or locally advanced disease. Multiple prognostic markers have been explored over the past 3 decades, but lymph node status remains the st...
1 CitationsSource
#1Mohamed E. Ahmed (Mayo Clinic)H-Index: 4
#2Mahmoud I. Khalil (University of Arkansas for Medical Sciences)H-Index: 8
Last. Philippe E. Spiess (USF: University of South Florida)H-Index: 35
view all 5 authors...
Management of penile cancer represents a challenge to urologic oncologists due to the disease’s rarity and sparse data in the literature. Squamous cell carcinoma represents the most common histologic subtype of penile cancer. Penile cancer has a disastrous effect on patients’ psychological and physical health. Penile cancer accounts for approximately 1% of cancer deaths in the USA annually. However, in recent years, the management of penile cancer has achieved marked progress in both diagnostic ...
1 CitationsSource
#1Anita ThomasH-Index: 1
#2Luisa Matos AlvimH-Index: 1
Last. Igor TsaurH-Index: 22
view all 8 authors...
1 CitationsSource
#1P.-H. SavoieH-Index: 4
#2N. Morel-JournelH-Index: 6
Last. Arnaud MejeanH-Index: 61
view all 8 authors...
Summary Objective. – To update French oncology guidelines concerning penile cancer. Methods. – Comprehensive Medline search between 2018 and 2020 upon diagnosis, treatment and follow-up of testicular germ cell cancer to update previous guidelines. Level of evidence was evaluated according to AGREE-II. Results. – Epidermoid carcinoma is the most common penile cancer histology. Physical examination is mandatory to define local and inguinal nodal cancer stage. MRI with artificial erection can help ...
1 CitationsSource
#1Florent PeyraudH-Index: 1
#1Florent Peyraud (University of Bordeaux)H-Index: 4
Last. Alain RavaudH-Index: 77
view all 11 authors...
Abstract Penile cancer (PeCa) is a rare disease worldwide, accounting for less than one percent of all malignancies in men. It usually presents as a painless ulcer or lump on the head of the penis. Squamous cell carcinoma represents the most common histological subtype of PeCa, with pathogenesis intimately linked to chronic Human Papilloma Virus (HPV) infection. Surgery is the cornerstone for the treatment of primary PeCa with potential mutilating outcome depending on the nodal extension of the ...
5 CitationsSource
Purpose Penile cancer is highly prevalent in low- and middle-income countries, with significant morbidity and mortality rates. The first Brazilian consensus provides support to improve penile cancer patients' outcomes, based on expert's opinion and evidence from medical literature. Methods Fifty-one Brazilian experts (clinical oncologists, radiation oncologists, urologists, and pathologists) assembled and voted 104 multiple-choice questions, confronted the results with the literature, and ranked...
Most patients with advanced penile cancer will have relapsed disease after cisplatin-based combination chemotherapy. Unfortunately, these patients have dismal outcomes with salvage chemotherapy, surgery, or radiation. In this review we will discuss the available chemotherapy and targeted therapies for salvage second line systemic treatment for patients with penile cancer. We will also summarize the ongoing interventional clinical trials using immune and human papilloma virus-based therapies.
1 CitationsSource
#1Ahmet M. AydinH-Index: 6
#1Ahmet M AydinH-Index: 2
Last. Philippe E. SpiessH-Index: 35
view all 8 authors...
The incidence of penile squamous cell carcinoma (PSCC) has increased in developed countries over the past decades owing to increased human papilloma virus (HPV) exposure. Despite successful surgical treatment of locoregional PSCC, effective treatment options for advanced disease are limited. The prognosis of patients with bulky nodal and metastatic PSCC is dismal and new management approaches are urgently needed. Genomic analyses have provided transformative knowledge on the genomic and molecula...
7 CitationsSource